{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:24:09Z","timestamp":1780471449552,"version":"3.54.1"},"reference-count":23,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2014,7,22]],"date-time":"2014-07-22T00:00:00Z","timestamp":1405987200000},"content-version":"vor","delay-in-days":4465,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Dermatology"],"published-print":{"date-parts":[[2002,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The study was designed to investigate the effects of dapsone in the treatment of mucocutaneous manifestations of Beh\u00e7et's disease and the possible prophylactic role of dapsone in a double blind\/placebo controlled clinical trial. Twenty patients diagnosed according to the International Study Group criteria as Beh\u00e7et's disease were included in the study. Patients were randomly allocated to receive either dapsone 100 mg daily or placebo for three months in a double\u2010blind manner. After three months, patients were crossed over and followed for a further three months. Patients were followed up in each visit by assessing the number, size, duration and frequency of oral and genital ulcers, other cutaneous manifestations, and systemic manifestations of the disease. A pathergy test was done on each visit. Laboratory investigations included hemoglobin concentration, white blood cell count, ESR, and C\u2010reactive protein. In dapsone\u2010treated patients, there were significant reductions in the oral and genital ulcer parameters as well as the incidence of other cutanous and systemic manifestations. In the placebo\u2010treated group, there were no significant changes in these parameters. The pathergy test result as well as those of other laboratory tests were all decreased in the dapsone\u2010treated group. Although this study was a small scale study, it shows that dapsone was effective in treatment of mucocutaneous manifestations of Beh\u00e7et's disease and possibly in prophylaxis against systemic manifestations of the disease. This result should lead to a larger scale study with a longer duration of follow\u2010up.<\/jats:p>","DOI":"10.1111\/j.1346-8138.2002.tb00263.x","type":"journal-article","created":{"date-parts":[[2014,7,22]],"date-time":"2014-07-22T10:22:34Z","timestamp":1406024554000},"page":"267-279","source":"Crossref","is-referenced-by-count":128,"title":["Dapsone in Beh\u00e7et's Disease: A Double\u2010Blind, Placebo\u2010Controlled, Cross\u2010Over Study"],"prefix":"10.1111","volume":"29","author":[{"given":"Khalifa E.","family":"Sharquie","sequence":"first","affiliation":[{"name":"Department of Dermatology College of Medicine, University of Baghdad  Baghdad Iraq"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafid A.","family":"Najim","sequence":"additional","affiliation":[{"name":"Department of Pharmacology College of Medicine, University of Baghdad  Baghdad Iraq"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed R.","family":"Abu\u2010Raghif","sequence":"additional","affiliation":[{"name":"Department of Pharmacology College of Medicine, University of Baghdad  Baghdad Iraq"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,7,22]]},"reference":[{"key":"e_1_2_5_2_1","first-page":"186","article-title":"Beh\u00e7et's disease","volume":"13","author":"Sharquie KE","year":"1990","journal-title":"Postgraduate Doctor Middle East"},{"key":"e_1_2_5_3_1","first-page":"1152","article-title":"Uber rezidiviende aphthose, durch ein virus verursachte geschwure am mund am auge und den genitalien","volume":"105","author":"Beh\u00e7et H","year":"1937","journal-title":"Dematol Wochenschr"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(99)70523-2"},{"key":"e_1_2_5_5_1","first-page":"1078","article-title":"Criteria for diagnosis of Beh\u00e7et's disease","volume":"335","author":"International Study Group for Beh\u00e7et's disease","year":"1990","journal-title":"Lancet"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002281-199401000-00007"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/34.10.932"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1984.tb04665.x"},{"key":"e_1_2_5_9_1","first-page":"48","article-title":"Treatment of Beh\u00e7et's disease with dapsone, Abstract\u20109th International Conference on Beh\u00e7et's disease","volume":"41","author":"Sharquie K","year":"2000","journal-title":"Yonsei Med J"},{"key":"e_1_2_5_10_1","unstructured":"DilsenN KoniceM AralO:The importance of positive pathergy test in the diagnosis of Beh\u00e7et's disease inHamzaM(ed):Proceeding of 3rd Mediterranean Congress of Rheumatology 1988 pp16\u201322."},{"key":"e_1_2_5_11_1","first-page":"47","volume-title":"Medical Biostatistics and Epidemiology: Examination and Board Revues","author":"Sorle DE","year":"1995"},{"key":"e_1_2_5_12_1","first-page":"236","volume-title":"Oral and Maxillofacial Pathology","author":"Neville BW","year":"1995"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1159\/000249548"},{"key":"e_1_2_5_14_1","first-page":"32","article-title":"The significance of laboratory tests in evaluating the clinical activity of Beh\u00e7et's disease. Abstract. 9th International Conference on Beh\u00e7et's disease","volume":"41","author":"Bang D","year":"2000","journal-title":"Yonsei Med J"},{"key":"e_1_2_5_15_1","unstructured":"KatzSI Sulfones inFitzPatrickTB FreedbergIM EisenAZ WolffK(eds):Dermatology in General Medicine 5th ed 1999 pp2790\u20132794."},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(75)80031-6"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1976.tb07036.x"},{"key":"e_1_2_5_18_1","unstructured":"AkogluT:New perspectives in the pathogenesis of Beh\u00e7et's disease(abstract) 8thInternational Congress on Beh\u00e7et's disease Reggio Emilia 1998 p63."},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI109109"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1982.tb00340.x"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(88)90256-7"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.19.4.495"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1997.tb06752.x"},{"key":"e_1_2_5_24_1","first-page":"1155","volume-title":"Goodman and Gilman's The Phaemacological Basis of Therapeutics","author":"Mandle JL","year":"1996"}],"container-title":["The Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1346-8138.2002.tb00263.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1346-8138.2002.tb00263.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T10:56:22Z","timestamp":1700304982000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1346-8138.2002.tb00263.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,5]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2002,5]]}},"alternative-id":["10.1111\/j.1346-8138.2002.tb00263.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1346-8138.2002.tb00263.x","archive":["Portico"],"relation":{},"ISSN":["0385-2407","1346-8138"],"issn-type":[{"value":"0385-2407","type":"print"},{"value":"1346-8138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,5]]}}}